Euglena revises FY2024 financial results, cites cash flow correction

Euglena Co. (TSE: 2931) has issued a correction to its previously released financial results for the year ended December 2024, with changes primarily affecting the consolidated cash flow statement. The correction involves revisions to line items and presentation formats within the cash flow statement, but does not impact other consolidated financial statements. Key changes include a revision to cash flow from operating activities, which has been adjusted to ¥2,645 million from the previously reported ¥3,420 million. Consequently, the company’s closing cash and cash equivalents balance at the end of FY2024 remains unchanged at ¥13,731 million. The company attributes the correction to a review of its initial reporting.